Article
Can human embryonic stem cell-derived stromal cells serve a starting material for myoblasts?
2017-03-23
Abstract excerpt
<h4>ABSTRACT</h4> A large number of myocytes is necessary to treat intractable muscular disorders such as Duchenne muscular dystrophy with cell-based therapies. However, starting materials for cellular therapy products such as myoblasts, marrow stromal cells, menstrual blood-derived cells and placenta-derived cells have a limited lifespan and cease to proliferate in vitro . From the viewpoints of manufacturing a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b6978911-0680-5118-9c78-98c94588e621
- DOI
- 10.1101/119693
